Foamix Pharmaceuticals Ltd.

CIK 1606645 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Foamix Pharmaceuticals Ltd..

Recent SEC filings

FiledFormAccession number
Mar 20, 2020EFFECT9999999995-20-000600
Mar 19, 202015-12B0001104659-20-035792
Mar 18, 2020S-8 POS0001104659-20-035409
Mar 18, 202040001209191-20-019905
Mar 18, 2020POS AM0001104659-20-035405
Mar 18, 2020S-8 POS0001104659-20-035413
Mar 18, 2020S-8 POS0001104659-20-035410
Mar 18, 2020S-8 POS0001104659-20-035407
Mar 12, 20208-K0001178913-20-000788
Mar 12, 202010-K0001178913-20-000792
Mar 11, 202040001209191-20-018202
Mar 11, 202040001209191-20-018193
Mar 11, 202040001209191-20-018194
Mar 11, 202040001209191-20-018195
Mar 11, 202040001209191-20-018196
Mar 11, 202040001209191-20-018192
Mar 11, 202040001209191-20-018199
Mar 11, 202040001209191-20-018204
Mar 11, 202040001209191-20-018190
Mar 11, 202040001209191-20-018198
Mar 11, 202040001209191-20-018197
Mar 10, 20208-K0001104659-20-030846
Mar 9, 202025-NSE0001354457-20-000112
Mar 3, 20204250001104659-20-028649
Mar 3, 202040001209191-20-015241